Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer
Top Cited Papers
Open Access
- 18 June 2021
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 9 (6), 689
- https://doi.org/10.3390/biomedicines9060689
Abstract
As a public health emergency of international concern, the highly contagious coronavirus disease 2019 (COVID-19) pandemic has been identified as a severe threat to the lives of billions of individuals. Lung cancer, a malignant tumor with the highest mortality rate, has brought significant challenges to both human health and economic development. Natural products may play a pivotal role in treating lung diseases. We reviewed published studies relating to natural products, used alone or in combination with US Food and Drug Administration-approved drugs, active against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and lung cancer from 1 January 2020 to 31 May 2021. A wide range of natural products can be considered promising anti-COVID-19 or anti-lung cancer agents have gained widespread attention, including natural products as monotherapy for the treatment of SARS-CoV-2 (ginkgolic acid, shiraiachrome A, resveratrol, and baicalein) or lung cancer (daurisoline, graveospene A, deguelin, and erianin) or in combination with FDA-approved anti-SARS-CoV-2 agents (cepharanthine plus nelfinavir, linoleic acid plus remdesivir) and anti-lung cancer agents (curcumin and cisplatin, celastrol and gefitinib). Natural products have demonstrated potential value and with the assistance of nanotechnology, combination drug therapies, and the codrug strategy, this “natural remedy” could serve as a starting point for further drug development in treating these lung diseases.Keywords
Funding Information
- the project of introduction and cultivation for young innovation talents in the colleges and universities of Shandong Province (Grant No. 614202, Grant No. 614901, and 615201)
This publication has 194 references indexed in Scilit:
- Impact of curcumin nanoformulation on its antimicrobial activityTrends in Food Science & Technology, 2018
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronavirusesScience Translational Medicine, 2017
- Control of autoimmune inflammation by celastrol, a natural triterpenoidPathogens and Disease, 2016
- Late Ebola virus relapse causing meningoencephalitis: a case reportThe Lancet, 2016
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeysNature, 2016
- Chemistry: Chemical con artists foil drug discoveryNature, 2014
- Targeted Polysaccharide Nanoparticle for Adamplatin Prodrug DeliveryJournal of Medicinal Chemistry, 2013
- Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro.2005
- Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives.2002
- Potent Inhibition of HIV Type 1 Replication by an Antiinflammatory Alkaloid, Cepharanthine, in Chronically Infected Monocytic CellsAIDS Research and Human Retroviruses, 1998